Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patientsRutger Koning, Esther J. Nossent, Nora Chekrouni et al.|Intensive Care Medicine|2021Cited by 132
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19Erik H Vogelzang, Lucas M. Fleuren, Floris C. Loeff et al.|The Journal of Immunology|2020Cited by 85
Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infectionLihui Guo, Robert Hemke, Brent Appelman et al.|EBioMedicine|2023Cited by 38
Age-related changes in plasma biomarkers and their association with mortality in COVID-19Erik H.A. Michels, Sabine Hermans, Brent Appelman et al.|European Respiratory Journal|2023Cited by 22
Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patientsRens Zonneveld, Janneke Horn, Suzanne Jurriaans et al.|Journal of Clinical Virology|2021Cited by 22